Complete Genomics, Inc. (GNOM) Posts Narrower than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts GNOM Hot Sheet
Join SI Premium – FREE
Complete Genomics, Inc. (NASDAQ: GNOM) reported Q1 EPS of ($0.48), $0.04 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $6.8 million versus the consensus estimate of $5.46 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- FGI Industries Ltd (FGI) Tops Q2 EPS by 59c
- Stantec (STN) Tops Q2 EPS by 47c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
